centerforbiosimilars19h
Prateek Yadav, MPTh, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars21h
A Banner Year for Biosimilars: The 19 FDA Approvals From 2024
In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...
centerforbiosimilars1d
Courtney Flaherty
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars2d
Lana Pine
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars2d
St John Skilton, PhD
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
FTC Releases Second Report on PBMs Meddling in Generic Drug Markets
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
centerforbiosimilars4d
Functional Similarity Between Ustekinumab Biosimilar ABP 654, Stelara in Crohn Disease
Functional similarity of the ustekinumab biosimilar ABP 654 (Wezlana) and the reference product (Stelara) was confirmed by a series of in vitro studies, which support the totality of evidence for the ...
centerforbiosimilars4d
Mayuri Mathuria, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars4d
Christina Corridon, MPH, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars4d
Adrian Goh, MEc
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars4d
Rosalind Wong, PharmD Candidate
The Top 5 Biosimilar Articles for the Week of December 2 ...